Qiagen Completes Acquisition Of Verogen, Strengthening Leadership In Human Id / Forensics With Ngs Technologies
Jan 09, 2023•over 2 years ago
Acquiring Company
QIAGEN N.V
Acquired Company
Verogen
VenloHealth CareBiotechnologyHealth CareDescription
QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) today announced it has completed the acquisition of Verogen, a leader in the use of next-generation sequencing (NGS) technologies to drive the future of human identification (HID) and forensic investigation.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed